Ebert, G
Pellegrini, M
Article History
First Online: 22 February 2016
Competing interests
: The Walter and Eliza Hall Institute of Medical Research has a research license agreement with TetraLogic Pharmaceuticals Corporation, Inc., the manufacturer of the cellular inhibitor of apoptosis protein antagonist birinapant. TetraLogic Pharmaceuticals Corporation, Inc., has filed a patent cooperation treaty application on behalf of The Walter and Eliza Hall Institute of Medical Research. MP provides consultative advice to TetraLogic Pharmaceuticals Corporation. GE owns stock in the company.